Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
AMRC
Fairly valued
Ameresco, Inc.
Price$23.75
Model IV$24.19
P/IV1.49
Discount 2%
Return to IV: +1.8%
Market implies +8.2%/yr
vs model +11.9% · below model
AMRN
Valuation N/A
AMARIN CORP PLCUK
Price$13.63
Model IV—
P/IV—
Market implies +39.2%/yr
vs model +2.0% · above model
AMRX
Overvalued
Amneal Pharmaceuticals, Inc.
Price$18.71
Model IV$15.96
P/IV0.83
Premium +17%
Return to IV: -14.7%
Owner yield 4.5%
10-yr IRR 9.4% · moderate
Market implies +9.9%/yr
vs model +9.7% · in line
AMRZ
Deeply overvalued
Amrize Ltd
Price$40.52
Model IV$29.27
P/IV1.86
Premium +38%
Return to IV: -27.8%
Owner yield 6.6%
10-yr IRR 9.7% · steady
Market implies +7.3%/yr
vs model +3.0% · above model
AMS
Deeply undervalued
AMERICAN SHARED HOSPITAL SERVICES
Price$1.42
Model IV$12.41
P/IV0.12
Discount 89%
Return to IV: +773.6%
Market implies -50.0%/yr
vs model +12.4% · below model
AMSC
Deeply overvalued
AMERICAN SUPERCONDUCTOR CORP /DE/
Price$30.19
Model IV$16.39
P/IV3.11
Premium +84%
Return to IV: -45.7%
Market implies +16.1%/yr
vs model +26.5% · below model
AMSF
Fairly valued
AMERISAFE INC
Price$24.62
Model IV$27.72
P/IV1.11
Discount 11%
Return to IV: +12.6%
AMSS
Valuation N/A
AMASS BRANDS
Price$0.67
Model IV—
P/IV—
AMST
Valuation N/A
Amesite Inc.
Price$1.08
Model IV—
P/IV—
Market implies +38.1%/yr
vs model +2.0% · above model
AMT
Fairly valued
AMERICAN TOWER CORP /MA/
Price$173.98
Model IV$181.13
P/IV1.03
Discount 4%
Return to IV: +4.1%
AMTB
Deeply overvalued
Amerant Bancorp Inc.
Price$29.80
Model IV$15.73
P/IV1.44
Premium +89%
Return to IV: -47.2%
AMTD
Valuation N/A
AMTD IDEA GROUP
Price$0.74
Model IV—
P/IV—
AMTM
Undervalued
Amentum Holdings, Inc.
Price$19.60
Model IV$24.48
P/IV0.95
Discount 20%
Return to IV: +24.9%
Owner yield 4.2%
10-yr IRR 12.6% · grower
Market implies +12.2%/yr
vs model +19.9% · below model
AMTX
Valuation N/A
AEMETIS, INC
Price$2.16
Model IV—
P/IV—
Market implies +43.4%/yr
vs model +3.0% · above model
AMUB
Valuation N/A
UBS AG
Price$23.74
Model IV—
P/IV—
AMWD
Fairly valued
AMERICAN WOODMARK CORP
Price$48.09
Model IV$48.57
P/IV0.99
Discount 1%
Return to IV: +1.0%
Owner yield 16.5%
10-yr IRR 27.8% · steady
Market implies +3.6%/yr
vs model +5.7% · in line
AMWL
Deeply overvalued
American Well Corp
Price$13.75
Model IV$8.54
P/IV1.15
Premium +61%
Return to IV: -37.9%
Market implies +6.3%/yr
vs model +2.0% · above model
AMX
Deeply overvalued
AMERICA MOVIL SAB DE CV/
Price$23.12
Model IV$17.26
P/IV1.34
Premium +34%
Return to IV: -25.3%
Owner yield 8.1%
10-yr IRR 8.3% · steady
Market implies +0.3%/yr
vs model -2.1% · in line
AMZE
Valuation N/A
AMAZE HOLDINGS, INC.
Price$0.15
Model IV—
P/IV—
Market implies +3.8%/yr
vs model +3.7% · in line
AMZN
Valuation N/A
AMAZON COM INC
Price$253.71
Model IV—
P/IV—
Market implies +39.3%/yr
AN
Overvalued
AUTONATION, INC.
Price$168.29
Model IV$142.96
P/IV0.16
Premium +18%
Return to IV: -15.1%
Owner yield 0.5%
10-yr IRR -17.7% · steady
Market implies +4.3%/yr
vs model +3.6% · in line
ANAB
Overvalued
ANAPTYSBIO, INC
Price$55.20
Model IV$47.56
P/IV1.17
Premium +16%
Return to IV: -13.8%
Market implies -1.2%/yr
vs model +38.8% · below model
ANDE
Deeply overvalued
Andersons, Inc.
Price$69.59
Model IV$49.42
P/IV1.43
Premium +41%
Return to IV: -29.0%
Market implies -3.0%/yr
vs model +2.0% · below model
ANDG
Valuation N/A
Andersen Group Inc.
Price$54.99
Model IV—
P/IV—
ANET
Deeply overvalued
Arista Networks, Inc.
Price$199.39
Model IV$62.15
P/IV2.57
Premium +221%
Return to IV: -68.8%
Owner yield 1.3%
10-yr IRR -2.0% · grower
Market implies +33.1%/yr
vs model +20.0% · above model
ANF
Fairly valued
ABERCROMBIE & FITCH CO /DE/
Price$135.76
Model IV$141.62
P/IV0.55
Discount 4%
Return to IV: +4.3%
Owner yield 7.1%
10-yr IRR 18.6% · grower
Market implies +9.5%/yr
vs model +12.8% · below model
ANGH
Valuation N/A
Anghami Inc
Price$3.65
Model IV—
P/IV—
ANGHW
Valuation N/A
Anghami Inc
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +26.5% · below model
ANGI
Overvalued
Angi Inc.
Price$5.30
Model IV$4.61
P/IV1.27
Premium +15%
Return to IV: -13.1%
Owner yield 26.7%
10-yr IRR 33.6% · steady
Market implies -0.5%/yr
vs model +0.1% · in line
ANGO
Deeply overvalued
ANGIODYNAMICS INC
Price$15.44
Model IV$6.05
P/IV1.90
Premium +155%
Return to IV: -60.8%
Market implies +11.8%/yr
vs model +2.0% · above model
ANGX
Deeply overvalued
Angel Studios, Inc.
Price$5.27
Model IV$1.66
P/IV1.67
Premium +218%
Return to IV: -68.6%
Market implies +20.6%/yr
vs model +15.0% · above model
ANIK
Deeply overvalued
Anika Therapeutics, Inc.
Price$20.81
Model IV$7.53
P/IV1.93
Premium +176%
Return to IV: -63.8%
Market implies +10.6%/yr
vs model +2.0% · above model
ANIP
Deeply undervalued
ANI PHARMACEUTICALS INC
Price$76.14
Model IV$369.54
P/IV0.21
Discount 79%
Return to IV: +385.3%
Owner yield 6.8%
10-yr IRR 19.7% · grower
Market implies -2.7%/yr
vs model +25.0% · below model
ANIX
Valuation N/A
Anixa Biosciences Inc
Price$2.77
Model IV—
P/IV—
ANL
Valuation N/A
Adlai Nortye Ltd.
Price$15.74
Model IV—
P/IV—
ANNA
Valuation N/A
AleAnna, Inc.
Price$3.27
Model IV—
P/IV—
Market implies +39.6%/yr
vs model +4.0% · above model
ANNAW
Deeply overvalued
AleAnna, Inc.
Price$0.26
Model IV$0.10
P/IV2.87
Premium +167%
Return to IV: -62.5%
Market implies +14.1%/yr
vs model +4.0% · above model
ANNX
Valuation N/A
Annexon, Inc.
Price$4.23
Model IV—
P/IV—
ANPA
Valuation N/A
Rich Sparkle Holdings Ltd
Price$2.05
Model IV—
P/IV—
Market implies +32.2%/yr
vs model +2.0% · above model
ANRO
Valuation N/A
Alto Neuroscience, Inc.
Price$30.27
Model IV—
P/IV—
ANSC
Valuation N/A
Agriculture & Natural Solutions Acquisition Corp
Price$11.46
Model IV—
P/IV—
ANSCU
Valuation N/A
ANSCU
Price$11.69
Model IV—
P/IV—
ANSCW
Valuation N/A
ANSCW
Price$0.00
Model IV—
P/IV—
ANSS
Valuation N/A
ANSS
Price$374.30
Model IV—
P/IV—
ANTA
Fairly valued
Antalpha Platform Holding Co
Price$3.31
Model IV$3.48
P/IV2.14
Discount 5%
Return to IV: +5.0%
ANTX
Valuation N/A
AN2 Therapeutics, Inc.
Price$5.05
Model IV—
P/IV—
ANVS
Valuation N/A
Annovis Bio, Inc.
Price$1.14
Model IV—
P/IV—
ANY
Deeply overvalued
Sphere 3D Corp.
Price$3.09
Model IV$1.94
P/IV0.98
Premium +60%
Return to IV: -37.4%
Market implies +9.7%/yr
vs model +31.7% · below model
AOD
Valuation N/A
abrdn Total Dynamic Dividend Fund
Price$10.52
Model IV—
P/IV—
AOMD
Valuation N/A
Angel Oak Mortgage REIT, Inc.
Price$25.07
Model IV—
P/IV—
AOMN
Valuation N/A
Angel Oak Mortgage REIT, Inc.
Price$25.28
Model IV—
P/IV—
AOMR
Valuation N/A
Angel Oak Mortgage REIT, Inc.
Price$7.90
Model IV—
P/IV—
AON
Deeply undervalued
Aon plc
Price$295.64
Model IV$424.70
P/IV0.74
Discount 30%
Return to IV: +43.7%
Owner yield 4.8%
10-yr IRR 10.3% · moderate
Market implies +3.1%/yr
vs model +9.7% · below model
AORT
Fairly valued
ARTIVION, INC.
Price$23.35
Model IV$25.28
P/IV0.88
Discount 8%
Return to IV: +8.3%
Market implies -8.0%/yr
vs model +10.2% · below model
AOS
Undervalued
SMITH A O CORP
Price$56.95
Model IV$74.89
P/IV0.76
Discount 24%
Return to IV: +31.5%
Owner yield 6.7%
10-yr IRR 12.9% · moderate
Market implies +2.1%/yr
vs model +7.0% · below model
AOSL
Deeply overvalued
ALPHA & OMEGA SEMICONDUCTOR Ltd
Price$25.40
Model IV$15.14
P/IV3.00
Premium +68%
Return to IV: -40.4%
Market implies +14.1%/yr
vs model +2.0% · above model
AOUT
Deeply overvalued
American Outdoor Brands, Inc.
Price$16.42
Model IV$7.91
P/IV1.28
Premium +108%
Return to IV: -51.9%
Market implies +10.9%/yr
vs model +2.0% · above model
AP
Fairly valued
AMPCO PITTSBURGH CORP
Price$8.35
Model IV$8.50
P/IV1.33
Discount 2%
Return to IV: +1.8%
Market implies +3.0%/yr
vs model +5.6% · in line
APA
Deeply undervalued
APA Corp
Price$44.87
Model IV$170.09
P/IV0.21
Discount 74%
Return to IV: +279.1%
Market implies -14.4%/yr
vs model +3.5% · below model
APAC
Valuation N/A
StoneBridge Acquisition II Corp
Price$10.26
Model IV—
P/IV—
